TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(0.50) Estimate, Sales $16.603M Beat $16.319M Estimate
TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(0.50) Estimate, Sales $16.603M Beat $16.319M Estimate
TELA Bio 2024年第一季度经调整后的每股收益美元（0.54）未达到预期（0.50），销售额为1660.3万美元，超过16319万美元的预期
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by 8 percent. This is a 14.29 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $16.603 million which beat the analyst consensus estimate of $16.319 million by 1.74 percent. This is a 39.42 percent increase over sales of $11.909 million the same period last year.
TELA Bio（纳斯达克股票代码：TELA）公布的季度亏损为每股0.54美元，比分析师普遍预期的0.50美元（0.50美元）低8％。这比去年同期每股亏损0.63美元（0.63美元）增长了14.29％。该公司公布的季度销售额为1660.3万美元，比分析师普遍预期的1631.9万美元高出1.74％。这比去年同期的1190.9万美元的销售额增长了39.42％。